- Ease of use
- After sales service
- Value for money
Description
Leica BOND-III, the fully automated IHC and ISH stainer that delivers what really matters: speed, efficiency and quality.
- Leica BOND-III is up to 50% faster than previous generation stainers
- Requires virtually no daily maintenance
- Class-leading quality with superior Bond reagents and proven Covertile™ technology.
With speed, efficiency and quality Leica BOND-III helps laboratories deliver what really matters: better patient care.
Reviews
Ronald Houston Status: See all reviews Member since 2012 Organization: Nationwide Children's Hospital Read more » | RATING: 4.7 
"The Bond III IHC system is by far the best automated platform on the market for clinical immunohistochemsitry and in-situ hybridization. Its openness, ease of use, consistency of high quality stains and both excellent sales and service support put it well above any other offerings. It is also fully supported by the Novocastra range of antibodies (as well as any other vendor antibody) and the polymer detection kit all adding to make it number 1. One failing in the past of Leica (and indeed most of its competitors) was that they tended to develop as they thought the customer would want. However, with the introduction of the "Voice of the Customer" approach, they are now listening to the customer's needs and following up with specific requests. There are many exciting new developments coming up in the near future. For those in the research market, the Bond Rx will fill the same needs as the Bond III does for the clinical market."   |
(what's this)
| Jeff Fill Status: See all reviews Member since 2012 Organization: Lilly Read more » | RATING: 4.3
"I have found Bond easy to use and have received great support from Leica for new developments. In the future I would like to see FISH capabilities developed." |
Feedback
Request info
Write a review
Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad 3 (All reviews published will be entered into the next drawing on May 31st 2013).
